TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.370
+0.100 (7.87%)
At close: May 12, 2025, 4:00 PM
1.370
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $77.53 million as of May 12, 2025. Its market cap has decreased by -79.15% in one year.
Market Cap
77.53M
Enterprise Value
-77.12M
1-Year Change
-79.15%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $77.53M, a decrease of -78.41%. That is a compound annual growth rate of -33.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 71.87M | -58.16% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |